Health & Wellness
10/10/2026 · Oneida & Power Region
Transgender Inmates Challenge Federal Prison Policy on Healthcare Access
Attorneys representing transgender inmates have urged the Supreme Court to maintain a lower court's order. This order currently blocks the Federal Bureau of Prisons from enforcing a new policy restricting healthcare and social accommodations for transgender prisoners. The policy, implemented by the Trump administration, eliminates access to hormone therapy and items like makeup and wigs.
Government Review Examines Diagnoses of ADHD and Autism in Young People
A recent government review focused on younger individuals and their diagnoses of ADHD and autism. The report highlighted a shift in diagnostic patterns over time. Officials involved in the review acknowledged evolving societal and clinical approaches.
10/09/2026
FDA to Conclude Abortion Pill Safety Review by March
The Food and Drug Administration (FDA) will finalize its safety review of mifepristone in March. A Louisiana federal judge mandated this update as part of a legal challenge seeking to reverse a policy allowing mail delivery of the abortion medication.
10/08/2026
GLP-1 Medications Show Potential in Addressing Addiction
New evidence suggests GLP-1 drugs, commonly used for diabetes and weight loss, may also reduce cravings for addictive substances. Scientists are conducting studies to determine if these medications can help individuals with substance use disorders. This research explores a potential new application for GLP-1s in public health.
10/08/2026
Report Examines Impact of Trump Administration's Drug Pricing Initiatives
A recent report evaluated the Trump administration's claims regarding drug prices, including the effectiveness of TrumpRx discounts. Findings indicate a mixed impact on prescription drug costs for consumers. The administration has asserted that the U.S. now pays the world's lowest drug prices.
10/08/2026
Cost of GLP-1 Medications Prompts Search for Alternatives
Many Americans face financial hurdles when trying to access GLP-1 medications. These cost barriers have prompted some patients to seek out alternative, unregulated versions. The situation highlights ongoing challenges in prescription drug affordability.
10/07/2026
Advertisement
Advertisement
Advertisement